Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M17,218Revenue (TTM) $M3,618Net Margin (%)14.0Altman Z-Score4.2
Enterprise Value $M17,862EPS (TTM) $6.7Operating Margin %10.9Piotroski F-Score6
P/E(ttm)35.0Beneish M-Score-2.7Pre-tax Margin (%)17.2Higher ROA y-yY
Price/Book10.010-y EBITDA Growth Rate %8.5Quick Ratio2.1Cash flow > EarningsN
Price/Sales4.95-y EBITDA Growth Rate %0.7Current Ratio2.6Lower Leverage y-yN
Price/Free Cash Flow47.4y-y EBITDA Growth Rate %48.3ROA % (ttm)9.9Higher Current Ratio y-yY
Dividend Yield %0.4PEG50.0ROE % (ttm)32.6Less Shares Outstanding y-yN
Payout Ratio %15.0Shares Outstanding M73.5ROIC % (ttm)14.0Gross Margin Increase y-yY

Gurus Latest Trades with BCR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BCRYacktman Fund 2016-09-30 Reduce-0.33%$213.02 - $239
($225.07)
$ 234.174%Reduce -15.38%550,000
BCRDonald Yacktman 2016-09-30 Reduce-0.13%$213.02 - $239
($225.07)
$ 234.174%Reduce -8.35%738,964
BCRTom Gayner 2016-09-30 Sold Out -0.06%$213.02 - $239
($225.07)
$ 234.174%Sold Out0
BCRJoel Greenblatt 2016-09-30 Reduce-0.01%$213.02 - $239
($225.07)
$ 234.174%Reduce -32.64%3,760
BCRDonald Yacktman 2016-06-30 Reduce-0.74%$202.67 - $235.16
($216.98)
$ 234.178%Reduce -36.85%806,300
BCRYacktman Fund 2016-06-30 Reduce-0.7%$202.67 - $235.16
($216.98)
$ 234.178%Reduce -27.78%650,000
BCRYacktman Focused Fund 2016-06-30 Sold Out -0.65%$202.67 - $235.16
($216.98)
$ 234.178%Sold Out0
BCRJoel Greenblatt 2016-06-30 Reduce-0.33%$202.67 - $235.16
($216.98)
$ 234.178%Reduce -96.30%5,582
BCRJoel Greenblatt 2016-03-31 Add0.32%$176.1 - $202.88
($188.46)
$ 234.1724%Add 1864.03%150,877
BCRVanguard Health Care Fund 2016-03-31 Sold Out -0.09%$176.1 - $202.88
($188.46)
$ 234.1724%Sold Out0
BCRDonald Yacktman 2016-03-31 Reduce-0.01%$176.1 - $202.88
($188.46)
$ 234.1724%Reduce -0.53%1,276,894
BCRVanguard Health Care Fund 2015-12-31 Reduce-0.23%$179.33 - $195.76
($187.31)
$ 234.1725%Reduce -71.10%226,841
BCRDonald Yacktman 2015-12-31 Reduce-0.22%$179.33 - $195.76
($187.31)
$ 234.1725%Reduce -12.33%1,283,759
BCRYacktman Focused Fund 2015-12-31 Reduce-0.21%$179.33 - $195.76
($187.27)
$ 234.1725%Reduce -30.00%140,000
BCRYacktman Fund 2015-12-31 Reduce-0.12%$179.33 - $195.76
($187.27)
$ 234.1725%Reduce -5.26%900,000
BCRTom Gayner 2015-12-31 Add0.03%$179.33 - $195.76
($187.31)
$ 234.1725%Add 125.00%9,000
BCRJoel Greenblatt 2015-12-31 Add0.01%$179.33 - $195.76
($187.31)
$ 234.1725%Add 94.19%7,682
BCRYacktman Focused Fund 2015-09-30 Reduce-1.86%$171.2 - $200.53
($189.23)
$ 234.1724%Reduce -78.95%200,000
BCRDonald Yacktman 2015-09-30 Reduce-1.19%$171.2 - $200.53
($189.23)
$ 234.1724%Reduce -47.20%1,464,225
BCRYacktman Fund 2015-09-30 Reduce-0.71%$171.2 - $200.53
($189.23)
$ 234.1724%Reduce -29.63%950,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BCR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Groetelaars John PGroup President 2017-01-11Sell573$235-0.35view
Lupisella Frank JrVice President and Controller 2017-01-10Sell2,945$2320.94view
Beasley Jim CGroup President 2016-12-30Sell4,709$2254.08view
Lupisella Frank JrVice President and Controller 2016-12-30Sell237$2263.62view
DeFord John ASr. VP Sci Tech and Clin Afrs 2016-12-12Sell15,883$218.037.4view
Beasley Jim CGroup President 2016-12-12Sell11,922$219.646.62view
WEILAND JOHN HVice Chairman, Pres. and COO 2016-12-12Sell11,190$219.676.6view
Luboff Sharon MGroup Vice President 2016-12-12Sell6,000$2196.93view
HOLLAND CHRISTOPHER SSenior Vice President and CFO 2016-10-28Sell5,724$211.1210.92view
RING TIMOTHY MChairman and CEO 2016-09-28Sell92,293$227.812.79view

Quarterly/Annual Reports about BCR:

News about BCR:

Articles On GuruFocus.com
Tom Gayner Sells 5 Holdings, Reduces 1 Other Dec 22 2016 
Dividend Aristocrats in Focus Part 25: CR Bard Nov 01 2016 
Timothy Ring, CEO and Chairman of C.R. Bard Inc., Sold 92,293 Shares of the Company on Sept. 28 Oct 01 2016 
Insider Trades: C.R. Bard, NVIDIA and Alphabet Sep 30 2016 
The Yacktman Focused Fund Sells Out of C.R. Bard Inc. Jul 19 2016 
5 Stocks Hit 52-Week High Prices Jul 11 2016 
5 Companies Have Hit 52-Week Highs Jun 21 2016 
5 Companies Achieve 52-Week Highs Jun 07 2016 
Dividends’ True Contribution to Total Return May Surprise You Mar 24 2016 
Medical Products Company CR Bard Has Stable Business Mar 09 2016 

More From Other Websites
C.R. Bard upgraded by Raymond James Jan 05 2017
Bard to Host Earnings Conference Call on January 26, 2017 Jan 04 2017
Bard to Host Earnings Conference Call on January 26, 2017 Jan 04 2017
C.R. Bard: High Growth, Low Risk? Jan 03 2017
Bard to Present at J. P. Morgan Healthcare Conference Jan 03 2017
BARD C R INC /NJ/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal... Dec 23 2016
Bard Declares Quarterly Dividend Dec 14 2016
C.R. Bard, Inc. (New Jersey) – Value Analysis (NYSE:BCR) : December 13, 2016 Dec 13 2016
C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bullish Manner : BCR-US :... Dec 12 2016
How C.R. Bard, Inc. (BCR) Stacks Up Against Twitter Inc (TWTR), Clorox and Other Peers Dec 10 2016
Bard to Present at the Citi Healthcare Conference Nov 30 2016
Bard to Present at the Piper Jaffray Healthcare Conference Nov 23 2016
BARD C R INC /NJ/ Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation... Nov 22 2016
CR Bard (BCR) Sees Hammer Chart Pattern: Time to Buy? Nov 17 2016
C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bullish Manner : BCR-US :... Nov 09 2016
Bard to Present at the Stifel Healthcare Conference Nov 08 2016
Dividend Aristocrats in Focus Part 25: CR Bard Nov 01 2016
BARD C R INC /NJ/ Financials Nov 01 2016
ETF’s with exposure to C.R. Bard, Inc. (New Jersey) : October 28, 2016 Oct 28 2016
BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report Oct 26 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)